|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
2.550 -0.070 (-2.672%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,595,487 | 1,653,796 | 182,371 | 1,033,449 |
| Net Cash from / (used in) Investing Activities | -- | (1,418,258) | (1,658,308) | (3,436,032) | 138,197 |
| Net Cash from / (used in) Financing Activities | -- | 841,599 | 54,148 | 1,878,897 | 253,981 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,018,828 | 49,636 | (1,374,764) | 1,425,627 |
| Cash & Cash Equivalents at beginning of period | -- | 2,323,740 | 2,438,252 | 3,865,385 | 2,327,349 |
| Effect of Foreign Exchange Rate Changes | -- | (103,595) | (164,148) | (52,369) | 112,409 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,238,973 | 2,323,740 | 2,438,252 | 3,865,385 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 387,836 |
| %Change | 158.597% |
| EPS / (LPS) | RMB 0.103 |
| NBV Per Share (¥) | RMB 3.461 |